Publication | Open Access
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
12
Citations
14
References
2016
Year
The test product was found to be bioequivalent and safe, and thus can be used interchangeably in clinical practice.
| Year | Citations | |
|---|---|---|
Page 1
Page 1